Caredx Overview
Is CDNA undervalued? Intrinsic value estimate stands at $-1.7.
Get informed when a big investor buys or sells
+ Follow$-1.70
Overvalued by 103.0% based on the discounted cash flow analysis.
Caredx (CDNA) currently reports a DCF fair value of $-1.7. Use the charts on this page to explore Caredx's DCF fair value history and peer comparisons.
Caredx's discounted cash flow (DCF) fair value estimate is $-1.7, about 103.0% overvalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $-1.7, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Caredx, and consider following CDNA for alerts when major investors trade the stock.
Caredx is classified in the Healthcare sector. On DCF fair value, it currently shows $-1.7. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CDNA with unrelated industries.
